Analysis of clinical, genetical, immunological and microbial factors in IBD patients to identify new prognostic and predictive factors to further optimize and personalize IBD management
Recruiting
- Conditions
- K50.1Ulcerative colitisK50K51Crohn disease [regional enteritis]Ulcerative colitis
- Registration Number
- DRKS00019082
- Lead Sponsor
- Medizinische Hochschule Hannover
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
IBD diagnosis > 3 months
• On ward/ out-patient treatment at the
Hannover medical school
• Signed informed consent
• Upcoming colonoscopic evaluation
• Caucasian ethnicity
Exclusion Criteria
Active Malignancies
• Hereditary Immunodeficiencies
• Any disorders which do not allow the
individual to assess the nature, scope and potential consequences of the clinical trial
• Other ethnicities then Caucasian
• Antibiotic use within the past 3 months
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Characterization of molecular changes in the context of the therapy response with regard to analyzes before and under the respective therapy.
- Secondary Outcome Measures
Name Time Method Evaluation of predictive Biomarkers